US Stocks
/
Maze Therapeutics, Inc. Share Price

Maze Therapeutics, Inc. Share Price

NASDAQ: MAZE | Small Cap
$25.89
-$0.36 (-1.37%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Maze Therapeutics, Inc. Stock Performance

Open
$25.25
Prev. Close
$26.25
Circuit Range
N/A
Day Range
$25.15 - $25.97
Year Range
$21.98 - $53.60
Volume
24,157
Average Traded
$25.53

Maze Therapeutics, Inc. Share Price Today

As of 9 October 2026, Maze Therapeutics, Inc.'s share price is $25.89. The stock opened at $25.25, compared to its previous close of $26.25. During today's trading session, Maze Therapeutics, Inc.'s share price traded between $25.15 and $25.97, with an average price of $25.56. Over the past 52 weeks, the stock has recorded a high of $53.60 and a low of $21.98. In terms of performance, Maze Therapeutics, Inc.'s share price has declined by 2.60% over the last six months and is down 21.21% on a year-on-year basis.

Maze Therapeutics, Inc. Share Price Chart

$25.15$25.97
L
Show Current Price
H

Maze Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.11B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.40
Revenue (TTM)
$0.00
Return On Equity (TTM)
-29.48%
Profit Margin
N/A
Debt to Equity
0.09
Quarterly Earnings Growth YoY
-48.65%

Maze Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$20.00$0.00
Net Profit-$30.09-$34.57-$24.21-$44.73
Net Profit MarginN/AN/A-121.05%N/A
Income ChangeN/A-14.89%29.97%-84.76%

Maze Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$0.00
Net Profit-$131.12
Net Profit MarginN/A
Income ChangeN/A

About Maze Therapeutics, Inc.

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.

Maze Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$27.14
$25.95
-4.58%
Sep 2026
$26.46
$27.20
-4.90%
Aug 2026
$26.00
$28.59
+6.22%
Jul 2026
$29.50
$26.92
-9.66%
Jun 2026
$25.82
$29.80
+12.71%
May 2026
$26.57
$26.44
-0.53%
Apr 2026
$30.89
$26.58
-10.72%
Mar 2026
$44.39
$29.77
-34.54%
Feb 2026
$43.59
$45.48
+4.29%
Jan 2026
$40.80
$43.61
+5.16%
Dec 2025
$37.44
$41.47
+9.78%
Nov 2025
$32.75
$37.77
+14.96%

MAZE Share Price FAQs

What is Maze Therapeutics, Inc. share price today?

chevron-up
Maze Therapeutics, Inc. share price today is $25.89 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Maze Therapeutics, Inc. stock?

chevron-up
The 52 week high of Maze Therapeutics, Inc. stock is $53.60, while the 52 week low is $21.98 as of 9 Oct '26.

What is MAZE's market capitalisation today?

chevron-up
MAZE market capitalisation is $1.11B as of October 9, 2026, at 4:47 pm IST.

What is MAZE's net income for the last quarter?

chevron-up
MAZE's net income for the last quarter is -44.73B USD.

What is the 5 year returns of MAZE?

chevron-up
The 5 year returns of MAZE is 62.32% as on 9 Oct '26.

What is the high & low stock price of MAZE today?

chevron-up
MAZE stock price hit a high of $25.97 and low of $25.15 as of 9 Oct '26.

Can I buy MAZE shares in India?

chevron-up
Yes. You can buy MAZE in India by opening an international trading account.